Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
| ▸ | NMBR | P28336 | 2/20 | 0.54 |
| ▸ | GHSR | Q92847 | 3/20 | 0.52 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.51 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.51 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.51 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29887063 | 1.00 | OPRM1 (0.55) | OPRM1OPRD1NMBRGHSRERAP2 | |
| SCHEMBL30011265 | 0.94 | NMBR (0.57) | OPRM1OPRD1NMBRGHSRERAP2 | |
| SCHEMBL31214602 | 0.87 | ERAP2 (0.57) | OPRM1OPRD1GHSRERAP2ERAP1 | |
| SCHEMBL31541502 | 0.87 | OPRM1 (0.55) | OPRM1OPRD1NMBRGHSRERAP2 | |
| SCHEMBL27619455 | 0.86 | CCKAR (0.49) | OPRM1OPRD1GHSRPRMT1 | |
| SCHEMBL29589496 | 0.86 | GHSR (0.54) | OPRM1OPRD1NMBRGHSR | |
| SCHEMBL27583742 | 0.86 | CCKAR (0.47) | OPRM1OPRD1NMBRGHSRERAP2 | |
| SCHEMBL31433302 | 0.85 | PRMT1 (0.57) | OPRM1OPRD1GHSRERAP2ERAP1 | |
| SCHEMBL29616865 | 0.85 | OPRD1 (0.64) | OPRM1OPRD1GHSR | |
| SCHEMBL30503003 | 0.85 | OPRD1 (0.68) | OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103059-A | Self-assembled nanoparticles based on amphiphilic peptides | 巴林萨斯生物疗法北美公司 | 2024-05-28 | — | — | CN | disclosed |